title: Gefitinib in the treatment of elderly patients with advanced non-small cell lung cancer (NSCLC).
authors.forename: Alessandra
authors.initials: A
authors.lastname: Bearz
authors.forename: Lucia
authors.initials: L
authors.lastname: Fratino
authors.forename: Simon
authors.initials: S
authors.lastname: Spazzapan
authors.forename: Massimiliano
authors.initials: M
authors.lastname: Berretta
authors.forename: Annalisa
authors.initials: A
authors.lastname: Giacalone
authors.forename: Cecilia
authors.initials: C
authors.lastname: Simonelli
authors.forename: Umberto
authors.initials: U
authors.lastname: Tirelli
mesh_terms: D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D000077156:Gefitinib; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D009367:Neoplasm Staging; D011799:Quinazolines / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D011799:Quinazolines; D000077156:Gefitinib